Top Analyst Upgrades and Downgrades: Andeavor, Discovery, Estee Lauder, Esperion Therapeutics, Hologic, Nvidia, Yum Brands and More

Print Email

The futures are once again looking lower this Thursday morning as Wall Street grapples with trade and tariff issues. Despite outstanding earnings reports for the first quarter, it seems as though every move higher in the market is met with renewed selling. While the Federal Reserve did not raise interest rates on Wednesday, it looks like a lock the gradual increases will continue. It has become clear that the multiyear trend of buying pullbacks is now more vulnerable to sellers, volatility and each major news headline. Many investors are finding it harder to decide how they want their assets positioned for the longer term.

24/7 Wall St. reviews dozens of analyst research reports each day of the week to find new investing ideas and trading ideas for our readers. Some of the top analyst reports cover stocks to buy. Other analyst calls cover stocks to sell or to avoid.

Additional color and commentary has also been added on some of these daily analyst calls. The consensus analyst price target data are from the Thomson Reuters sell-side research service.

These were the top analyst upgrades, downgrades and other research calls from Thursday, May 3, 2018.

Andeavor (NYSE: ANDV) was raised to Buy from Hold at Jefferies. The company recently was purchased by Marathon Petroleum in a massive $23.3 billion deal. Andeavor’s 52-week trading range is $78.35 to $144.08. The Wall Street consensus price target for the shares is $135.17. The stock closed above that level on Wednesday at $138.58.

Clean Harbors Inc. (NYSE: CLH) was raised to Outperform from Perform at Baird with a $61 price target. The analysts at Canaccord Genuity also raised the stock to Buy from Neutral, and they have a $60 price target. That compares with the consensus target of $57.70. The 52-week trading range is $44.75 to $61.62. Both upgrades come on the back of a solid earnings report. The shares closed Wednesday at $49.18.

Clearwater Paper Corp. (NYSE: CLW) was raised to Outperform from Perform at RBC with a $30 price target. That compares with the consensus target of $46.75. The 52-week trading range is $22.51 to $50.60. The stock closed Wednesday at $23.

Discovery Inc. (NASDAQ: DISCA) was raised to Overweight from Equal Weight at JPMorgan, which also has a $29 price target. The Wall Street consensus target is $26.77. The stock has traded in a 52-week range of $15.99 to $29.72. The shares closed Wednesday at $23.58.

EnLink Midstream LLC (NYSE: ENLC) was raised to Outperform from Perform at RBC, which has its price target set at $22. The consensus target price is $17.50. The shares have traded in a 52-week range of $13.80 to $20. The stock closed Wednesday at $15.20.

Esperion Therapeutics Inc. (NASDAQ: ESPR) was downgraded to Underweight from Equal Weight at JPMorgan, which has a price objective of $41. That compares with the consensus target of $100.54. The stock has traded in a 52-week range of $30.95 to $82.68. The shares were absolutely crushed on Wednesday as Phase 3 results for one of the company’s key drugs showed safety results issues. The shares closed at $45.75, down a stunning 35% on the day.

Follow @Jonogg on Twitter to receive the daily analyst calls and other market research calls directly on your feed.